Accessibility Menu
AusCann Group logo

AusCann Group(ASX) AC8

This security has been delisted. This page is retained for historical reference.

AusCann Group last closing stock price
MetricPriceDate
Last closeAUD 0.042022-08-31
AusCann Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%AUD 0.042022-08-24
1 month-9.09%AUD 0.042022-08-01
3 month-27.27%AUD 0.062022-06-02
Year to date-50.62%AUD 0.082021-12-31
1 year-57.45%AUD 0.092021-08-31
3 year-89.61%AUD 0.392019-08-30
5 year-92.38%AUD 0.532017-09-01
Since inception-81.82%AUD 0.222017-02-03

AC8 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

AC8 Financials

Key Financial Metrics (TTM)

Gross Margin

95.84%

Operating Margin

-124.75%

Net Income Margin

-977.06%

Return on Equity

-61.32%

Return on Capital

-8.06%

Return on Assets

-147.56%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

A$562.30K

Operating Income

-A$12.86M

EBITDA

-A$12.46M

Operating Cash Flow

-A$4.24M

Capital Expenditure

-A$42.34K

Free Cash Flow

-A$4.29M

Cash & ST Invst.

A$3.68M

Total Debt

A$0.00

AusCann Group Performance Analysis

AusCann Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 24,600N/A
20232023-06-30AUD 0N/A
AusCann Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42022-06-30497.6%
Q22022-12-30-89.1%
Q42023-06-30-100.0%
Q22023-12-30N/A
AusCann Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.06N/A
20232023-06-30AUD -0.02-58.9%
AusCann Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42022-06-30-525.6%
Q22022-12-3087.7%
Q42023-06-30-620.0%
Q22023-12-3099.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

A$0.00

-100.0%

Gross Profit

-A$252.00

+99.9%

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

27

N/A

Net Income

-A$103.87K

+94.0%

EBITDA

-A$515.52K

+60.0%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Total Cash

A$3.68M

-73.1%

Total Debt

A$0.00

-100.0%

Accounts Receivable

A$170.00

-99.9%

Inventory

A$0.00

-100.0%

Long Term Debt

A$0.00

-100.0%

Short Term Debt

A$0.00

-100.0%

Return on Assets

-1.48%

N/A

Return on Invested Capital

-19.23%

N/A

Free Cash Flow

-A$627.76K

+44.4%

Operating Cash Flow

-A$627.76K

+44.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MXC.AXMGC Pharmaceuticals Limited
A$0.42+2.44%
IHL.AXIncannex Healthcare Limited
A$0.04-10.87%
CPH.AXCreso Pharma Limited
A$0.01+0.00%
1ST.AX1st Group Limited
A$0.01+22.22%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.23+0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.76+0.01%
ONDSOndas
$9.24+0.04%
SPCXSpace Exploration Technologies
$140.00-0.01%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.